Precemtabart Tocentecan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Precemtabart Tocentecan, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) [Phase 3]